These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7512026)

  • 1. Effects of clonidine and IBMX on sulfobromophthalein disposition in rats.
    Agbaria R; Hurwitz A; Ben-Zvi Z
    Eur J Drug Metab Pharmacokinet; 1993; 18(3):239-45. PubMed ID: 7512026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonidine effects on sulfobromophthalein disposition in mice.
    Ben-Zvi Z; Hurwitz A
    J Pharmacol Exp Ther; 1985 Nov; 235(2):393-7. PubMed ID: 4057076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of morphine and clonidine on sulphobromophthalein disposition in mice.
    Ben-Zvi Z; Hurwitz A
    J Pharm Pharmacol; 1986 Jun; 38(6):481-3. PubMed ID: 2873230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary clearance of bromosulfophthalein in anesthetized and freely moving conscious rat.
    Oh JH; Park SE; Shim CK; Lee YJ
    Biopharm Drug Dispos; 2009 Mar; 30(2):94-8. PubMed ID: 19226651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent conjugation of sulfobromophthalein and hepatic transit time in bile fistula rats: role of the microtubule-dependent vesicle pathway.
    Tazuma S; Horikawa K; Ochi H; Nishioka T; Sunami Y; Yasumiba S; Asamoto Y; Tsuboi K; Nakai K; Sakomoto M; Kanno K; Yamaguchi A; Numata Y; Chayama K
    Dig Dis Sci; 2001 Jun; 46(6):1285-9. PubMed ID: 11414306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narcotic effects on hepatic disposition of sulfobromophthalein in rats.
    Hurwitz A; Fischer HR
    J Pharmacol Exp Ther; 1983 Oct; 227(1):68-72. PubMed ID: 6620173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid effects on hepatic disposition of dyes in mice.
    Hurwitz A; Fischer HR; Innis JD; Ronsse S; Ben-Zvi Z
    J Pharmacol Exp Ther; 1985 Mar; 232(3):617-23. PubMed ID: 3973820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sulfobromophthalein (BSP) and sulfobromophthalein glutathione (BSP-GSH) disposition under conditions of altered liver function and in the isolated perfused rat liver.
    Yam J; Reeves M; Roberts RJ
    J Lab Clin Med; 1976 Mar; 87(3):373-83. PubMed ID: 1249471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adrenoceptor agonists and antagonists on sulfobromophthalein disposition in mice.
    Ben-Zvi Z; Hurwitz A
    Eur J Pharmacol; 1987 Jun; 137(2-3):191-6. PubMed ID: 3609141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonidine effects on disposition of xenobiotics in rats: inhibited elimination of flow-limited but not extraction-limited agents.
    Ben-Zvi Z; Hurwitz A
    Br J Pharmacol; 1988 May; 94(1):97-102. PubMed ID: 3401645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of cholic acid and dehydrocholic acid on the biliary excretion of unconjugated and conjugated sulfobromophthalein in rats.
    Schulze PJ; Czok G; Meyer H
    Arzneimittelforschung; 1976; 26(10):1894-903. PubMed ID: 1037210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of oral diazepam pretreatment on the biliary excretion of sulfobromophthalein in rats.
    Hanasono GK; de Repentigny L; Priestly BG; Plaa GL
    Can J Physiol Pharmacol; 1976 Aug; 54(4):603-12. PubMed ID: 974887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to effects of clonidine and morphine on sulfobromophthalein disposition in mice.
    Ben-Zvi Z; Graham CE; Hurwitz A
    Life Sci; 1987 Apr; 40(16):1617-23. PubMed ID: 3561168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of various cytochrome P450 3A and P-glycoprotein modulators on the biliary clearance of bromosulphaphthalein in male wistar rats.
    Machavaram KK; Gundu J; Yamsani MR
    Pharmazie; 2004 Dec; 59(12):957-60. PubMed ID: 15638086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient biliary excretion of susalimod, probably via the bromosulphthalein carrier, studied in a chronic bile fistula model in dogs.
    Påhlman I; Wilén M; Bowald S
    J Pharm Pharmacol; 1999 Jan; 51(1):61-6. PubMed ID: 10197419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, hepatic biotransformation and biliary and urinary excretion of bromosulfophthalein (BSP) in an experimental liver disease mimicking biliary cirrhosis.
    Esteller A; Torres MD; Gomez-Bautista M; Mariño EL; Fernandez-Lastra C; Jimenez R
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):7-14. PubMed ID: 2384120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma disappearance and biliary excretion of bromosulfophthalein in styrene-treated and styrene oxide-treated rats.
    Chakrabarti S; Brodeur J
    J Toxicol Environ Health; 1981 Oct; 8(4):609-17. PubMed ID: 7338933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial characterization of mechanism(s) by which sulphobromophthalein reduces biliary lipid secretion.
    Yamashita G; Tazuma S; Horikawa K; Aihara N; Ochi H; Teramen K; Yamashita Y; Sasaki M; Ohya T; Kajiyama G
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):173-7. PubMed ID: 8471036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in the effects of ursodeoxycholate and its taurine conjugate on the biliary excretion of sulfobromophthalein in the rat.
    Kanai S; Kitani K; Sato Y
    J Hepatol; 1990 Mar; 10(2):174-9. PubMed ID: 2332588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic transport and biliary excretion of sulfobromophthalein in aflatoxin B1-treated rats.
    Carrillo MC; Rodriguez JV; Monti JA; Rodriguez Garay EA
    Toxicol Appl Pharmacol; 1985 Feb; 77(2):353-7. PubMed ID: 3919465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.